Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging

Journal: Genome Research

Published: 2019-06-03

DOI: 10.1101/gr.243584.118

Affiliations: 21

Authors: 26

Go to article
Institutions Share
Institute of Biomedical and Clinical Science, University of Exeter, United Kingdom (UK) 0.23
Human Genetics and Genomic Medicine, Soton, United Kingdom (UK) 0.11
Institute of Medical Genetics, University Hospital of Wales, United Kingdom (UK) 0.08
Genetics Research Centre, SGUL, United Kingdom (UK) 0.07
Centre d'Investigation Clinique de Besançon, France 0.04
College of Medicine - Tucson, Arizona, United States of America (USA) 0.04
Department of Clinical Genetics, Rigshospitalet, Denmark 0.04
Northern Ireland Regional Genetics Centre, Belfast City Hospital, United Kingdom (UK) 0.04
Monash Genetics, Monash Health, Australia 0.04
NYU Division of Clinical Genetic Services, United States of America (USA) 0.04
Department of Clinical Genetics, UHBristol, United Kingdom (UK) 0.04
ASST Lariana, Italy 0.04
Department of Paediatrics, Monash University, Australia 0.04
Genetics Service, University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.04
Princess Anne Hospital, University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.04
North East Thames Regional Genetics Service, GOSH, United Kingdom (UK) 0.02
Department of Clinical Genetics, GOSH, United Kingdom (UK) 0.02
ICR Division of Genetics and Epidemiology, United Kingdom (UK) 0.01
South West Thames Regional Genetics Service, United Kingdom (UK) 0.01
Peninsula Clinical Genetics Service (PCGS), United Kingdom (UK) 0.01
Royal Devon and Exeter Hospital, United Kingdom (UK) 0.01

Return